Sensyne Health PLC
LSE:SENS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sensyne Health PLC
Capital Expenditures
Sensyne Health PLC
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sensyne Health PLC
LSE:SENS
|
Capital Expenditures
-£5.9m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Renalytix PLC
LSE:RENX
|
Capital Expenditures
-$200k
|
CAGR 3-Years
-56%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Capital Expenditures
-$16.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-24%
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Capital Expenditures
-£30k
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
Capital Expenditures
-£2.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
P
|
Physitrack PLC
STO:PTRK
|
Capital Expenditures
-€2.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Sensyne Health PLC
Glance View
Sensyne Health Plc is a healthcare technology company, which engages in the discovery and development of new medicines. The firm offers SENSIGHT platform, which provides a research environment for pharmaceutical and life science companies to analyze deidentified and anonymized patient data to support all stages of research and development. The firm applies clinical artificial intelligence (AI) in the healthcare and life science industries. In healthcare, the Company delivers remote patient monitoring and real-time decision-making systems for healthcare organizations and their patients. In life sciences, the Company analyses anonymized data sets to help life sciences companies to develop medicines. The firm's healthcare products include a variety of applications, including decision-making support, remote patient monitoring, diagnostics, prescribed digital therapeutics and the recording and presentation of healthcare data in a clinical setting.
See Also
What is Sensyne Health PLC's Capital Expenditures?
Capital Expenditures
-5.9m
GBP
Based on the financial report for Apr 30, 2021, Sensyne Health PLC's Capital Expenditures amounts to -5.9m GBP.
What is Sensyne Health PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-115%
Over the last year, the Capital Expenditures growth was -171%. The average annual Capital Expenditures growth rates for Sensyne Health PLC have been -115% over the past three years .
